Skip to main content

Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey.

Publication ,  Journal Article
Gold, T; Williams, SA; Weiss, RJ; Wang, Y; Watkins, C; Carroll, J; Middleton, C; Silverman, S
Published in: J Drug Assess
2019

Objective: To evaluate the impact of osteoporosis-related fractures on health-related quality of life (HRQoL). Methods: Data were obtained from the 2016 Adelphi US Osteoporosis Disease Specific Programme™, a cross-sectional survey of physicians and their male and female patients with osteoporosis. Patient-reported outcomes (PRO) measures included the European Quality of Life 5 Domains (EQ-5D), European Quality of Life Visual Analog Scale (EQ-VAS), and Osteoporosis Assessment Questionnaire short-version (OPAQ-SV; physical, emotional, and symptom domains). Associations between PRO scores and the number and site of fractures were evaluated using ANOVA. Multivariate analyses were conducted using linear regression. Results: Physicians provided records for 1848 patients with osteoporosis. Of these, 981 (53.1%) completed the patient survey, data for the number of fractures were available for 935/981 (95.3%), and 185/935 (19.8%) had a history of fracture. Experiencing fractures significantly influenced scores on all PRO measures (p < .0001). Hip and spine fractures were associated with the greatest reduction in most PRO scores. The number of fractures, age, body mass index, and Charlson Comorbidity Index (CCI) were significantly associated with PRO measures (p < .05) in multivariate analyses. In patients with a fracture, fracture site, CCI, gender (EQ-5D and EQ-VAS), and age (OPAQ-SV physical only) were significantly associated with PRO measures. Conclusions: In patients with osteoporosis, fractures are associated with lower HRQoL and lower overall health status. Fracture history, fracture site, age, and comorbidity burden significantly influence HRQoL in individuals with osteoporosis. These data suggest the need for interventions to reduce the risk of fractures in patients with osteoporosis.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Drug Assess

DOI

ISSN

2155-6660

Publication Date

2019

Volume

8

Issue

1

Start / End Page

175 / 183

Location

England
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gold, T., Williams, S. A., Weiss, R. J., Wang, Y., Watkins, C., Carroll, J., … Silverman, S. (2019). Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey. J Drug Assess, 8(1), 175–183. https://doi.org/10.1080/21556660.2019.1677674
Gold, T., Setareh A. Williams, Richard J. Weiss, Yamei Wang, Christopher Watkins, James Carroll, Chloe Middleton, and Stuart Silverman. “Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey.J Drug Assess 8, no. 1 (2019): 175–83. https://doi.org/10.1080/21556660.2019.1677674.
Gold T, Williams SA, Weiss RJ, Wang Y, Watkins C, Carroll J, et al. Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey. J Drug Assess. 2019;8(1):175–83.
Gold, T., et al. “Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey.J Drug Assess, vol. 8, no. 1, 2019, pp. 175–83. Pubmed, doi:10.1080/21556660.2019.1677674.
Gold T, Williams SA, Weiss RJ, Wang Y, Watkins C, Carroll J, Middleton C, Silverman S. Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey. J Drug Assess. 2019;8(1):175–183.

Published In

J Drug Assess

DOI

ISSN

2155-6660

Publication Date

2019

Volume

8

Issue

1

Start / End Page

175 / 183

Location

England